|
|
Article: New Report Suggests Hedgehog Pathway Stimulation Improves Wound Healing in Diabetic Wound Model.
- Article from:
- Business Wire
- Article date:
- May 9, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CAMBRIDGE, Mass. -- Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company, today announced that a new report has documented the beneficial effects of Hedgehog pathway stimulation for accelerated wound closure in an animal model of diabetes-impaired wound healing. Poorly healing wounds, in part due to impaired circulation, are often a major complication of diabetes, which afflicts an estimated 18 million Americans. Diabetic wounds can lead to severe complications if left untreated. For example, more than 60% of non-traumatic lower-limb amputations in the United States occur among people with diabetes.
The new study was presented at the 66th Annual ...
Related newspaper, magazine, and journal articles:
|
|
Article: Curis Receives Extended Cancer Program Funding from ...
Business Wire;
April 14, 2005 ;
700+ words
... ... pathway inhibitors to treat solid tumors Curis, Inc. (NASDAQ: CRIS), a therapeutic ... 2 million will be provided to support Curis personnel and other third party resources dedicated to developing Curis' Hedgehog inhibition technologies for ...
|
|